Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis (Q28320667)

Europe PubMed Central

PubMed publication ID

1621752

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1621752

16 October 2022

W. Bischoff

2

1 reference

Europe PubMed Central

PubMed publication ID

1621752

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1621752

full work available at URL

16 October 2022

language of work or name

English

0 references

publication date

22 June 1992

0 references

https://api.elsevier.com/content/article/PII:000293439290614H?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

https://api.elsevier.com/content/article/PII:000293439290614H?httpAccept=text/plain

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

American Journal of Medicine

16 October 2022

published in

0 references

volume

92

0 references

issue

6A

0 references

page(s)

86S-94S

0 references

cites work

Advances in the understanding and treatment of urinary tract infections in young women

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. A randomized trial

16 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Management of acute pyelonephritis in an emergency department observation unit

16 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Treatment of pyelonephritis in an observation unit

16 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Pyelonephritis in adult women: inpatient versus outpatient therapy

16 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

In-vitro activity and beta-lactamase stability of LY163892.

16 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Comparative in-vitro activity of a new oral carbacephem, LY163892.

16 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Antimicrobial activity of LY163892, an orally administered 1-carbacephem

16 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

In vitro activities of LY163892, cefaclor, and cefuroxime

16 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

In vitro activity and beta-lactamase stability of LY163892.

16 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.

16 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Amoxicillin-clavulanic acid versus cefaclor in the treatment of urinary tract infections and their effects on the urogenital and rectal flora

16 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections

16 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome

16 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections

16 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins

16 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

The effect of prescribed daily dose frequency on patient medication compliance

16 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90614-H

16 October 2022

Identifiers

1 reference

National Center for Biotechnology Information

PubMed publication ID

1621752